{
  "run_id": "RUN_20260203_174258_0a58abccb18d",
  "timestamp": "2026-02-03T19:53:22.217476",
  "document": "Primary-Central-Nervous-System-Lymphoma.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/dev/Primary-Central-Nervous-System-Lymphoma.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 12,
  "total_validated": 12,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "diseases": [
    {
      "matched_text": "PCNSL",
      "preferred_label": "Microglioma",
      "abbreviation": null,
      "confidence": 1.0,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": null,
        "orpha": null,
        "umls": "C0280803",
        "mesh": null
      },
      "all_identifiers": [
        {
          "system": "UMLS",
          "code": "C0280803",
          "display": null
        }
      ],
      "context": "Primary central nervous system lymphoma constitutes 4% of all brain tumors and develops in around five individuals per million each year, for a total of approximately 1,500 new cases per year in the United States. PCNSL is slightly more common in males. The most common risk factor for the development of a primary CNS lymphoma is an impaired immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell",
      "page": 1,
      "mention_count": 3,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "scispacy_ner",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "all",
      "preferred_label": "leukemia, acute lymphocytic, susceptibility to, 1",
      "abbreviation": null,
      "confidence": 0.6,
      "is_rare_disease": false,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0013108",
        "orpha": null,
        "umls": "UMLS:C2751595",
        "mesh": null
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0013108",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:442767",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "OMIM:613065",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C2751595",
          "display": null
        }
      ],
      "context": "Primary central nervous system lymphoma constitutes 4% of all brain tumors and develops in around five individuals per million each year, for a total of approximately 1,500 new cases per year in the United States. PCNSL is slightly more common in males. The most common risk factor for the development of a primary CNS lymphoma is an impaired immune system (imm",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "common",
      "preferred_label": "common",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0021137",
        "orpha": null,
        "umls": null,
        "mesh": "D003139"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0021137",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D003139",
          "display": "Common Cold"
        }
      ],
      "context": "Primary central nervous system lymphoma constitutes 4% of all brain tumors and develops in around five individuals per million each year, for a total of approximately 1,500 new cases per year in the United States. PCNSL is slightly more common in males. The most common risk factor for the development of a primary CNS lymphoma is an impaired immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosupp",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Carotid Artery Diseases",
        "Carotid Stenosis",
        "Common Bile Duct Diseases"
      ],
      "pubtator_normalized_name": "Common Cold",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "primary CNS lymphoma",
      "preferred_label": "primary central nervous system lymphoma",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0002571",
        "orpha": "Orphanet:46135",
        "umls": "UMLS:C0280803",
        "mesh": null
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0002571",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:3234",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:1000157",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:9318",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:200.5",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:79187",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10036685",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C9301",
          "display": null
        },
        {
          "system": "NORD",
          "code": "NORD:2002",
          "display": null
        },
        {
          "system": "ONCOTREE",
          "code": "ONCOTREE:PCNSL",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:46135",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:307649006",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0280803",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1133193893",
          "display": null
        }
      ],
      "context": "central nervous system lymphoma constitutes 4% of all brain tumors and develops in around five individuals per million each year, for a total of approximately 1,500 new cases per year in the United States. PCNSL is slightly more common in males. The most common risk factor for the development of a primary CNS lymphoma is an impaired immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosuppressed groups include organ transplant recipients and individuals with congenital im",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "AIDS",
      "preferred_label": "AIDS",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0012268",
        "orpha": null,
        "umls": "UMLS:C0001175",
        "mesh": "MESH:D000163"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0012268",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:635",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0000765",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:99",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D000163",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200809",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C2851",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:62479008",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0001175",
          "display": null
        }
      ],
      "context": "year, for a total of approximately 1,500 new cases per year in the United States. PCNSL is slightly more common in males. The most common risk factor for the development of a primary CNS lymphoma is an impaired immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosuppressed groups include organ transplant recipients and individuals with congenital immunodeficiency syndromes. In fact, primary CNS lymphoma is the most common brain tumor in immunosuppressed pa",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "AIDS-Associated Nephropathy",
        "AIDS Dementia Complex",
        "HIV Seropositivity"
      ],
      "pubtator_normalized_name": "Acquired Immunodeficiency Syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "congenital",
      "preferred_label": "congenital",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0021140",
        "orpha": null,
        "umls": null,
        "mesh": "D000013"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0021140",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1048408993",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D000013",
          "display": "Congenital Abnormalities"
        }
      ],
      "context": "CNS lymphoma is an impaired immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosuppressed groups include organ transplant recipients and individuals with congenital immunodeficiency syndromes. In fact, primary CNS lymphoma is the most common brain tumor in immunosuppressed patients. The other main risk factor for developing a PCNSL is age. Most immunocompetent patients are diagnosed around age 60, although cases of PCNSL have also been reported in children. AI",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Congenital Hereditary and Neonatal Diseases and Abnormalities",
        "Congenital central hypoventilation syndrome",
        "Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects"
      ],
      "pubtator_normalized_name": "Congenital Abnormalities",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "immunodeficiency",
      "preferred_label": "immunodeficiency",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "immunology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0021094",
        "orpha": null,
        "umls": "UMLS:C0021051",
        "mesh": "D000163"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0021094",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:279.3",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:7034",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2100204",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3131",
          "display": null
        },
        {
          "system": "OMIMPS",
          "code": "OMIMPS:300755",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:234532001",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0021051",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D000163",
          "display": "Acquired Immunodeficiency Syndrome"
        }
      ],
      "context": "ma is an impaired immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosuppressed groups include organ transplant recipients and individuals with congenital immunodeficiency syndromes. In fact, primary CNS lymphoma is the most common brain tumor in immunosuppressed patients. The other main risk factor for developing a PCNSL is age. Most immunocompetent patients are diagnosed around age 60, although cases of PCNSL have also been reported in children. AIDS-related PCNSL",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Immunodeficiency due to Defect in MAPBP-Interacting Protein",
        "Lymphoproliferative Disorders",
        "X-Linked Combined Immunodeficiency Diseases"
      ],
      "pubtator_normalized_name": "Acquired Immunodeficiency Syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "syndromes",
      "preferred_label": "syndromic disease",
      "abbreviation": null,
      "confidence": 0.65,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0002254",
        "orpha": null,
        "umls": "UMLS:C0039082",
        "mesh": "MESH:D013577"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0002254",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:225",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:11688",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D013577",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C28193",
          "display": null
        },
        {
          "system": "OGMS",
          "code": "OGMS:0000086",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0039082",
          "display": null
        }
      ],
      "context": "immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosuppressed groups include organ transplant recipients and individuals with congenital immunodeficiency syndromes. In fact, primary CNS lymphoma is the most common brain tumor in immunosuppressed patients. The other main risk factor for developing a PCNSL is age. Most immunocompetent patients are diagnosed around age 60, although cases of PCNSL have also been reported in children. AIDS-related PCNSL most often",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Mental retardation X-linked syndromic 5",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "brain tumor",
      "preferred_label": "Brain Neoplasms",
      "abbreviation": null,
      "confidence": 1.0,
      "is_rare_disease": false,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": null,
        "orpha": null,
        "umls": "C0006118",
        "mesh": "D001932"
      },
      "all_identifiers": [
        {
          "system": "UMLS",
          "code": "C0006118",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D001932",
          "display": "Brain Neoplasms"
        }
      ],
      "context": "of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosuppressed groups include organ transplant recipients and individuals with congenital immunodeficiency syndromes. In fact, primary CNS lymphoma is the most common brain tumor in immunosuppressed patients. The other main risk factor for developing a PCNSL is age. Most immunocompetent patients are diagnosed around age 60, although cases of PCNSL have also been reported in children. AIDS-related PCNSL most often develop during the fifth decade of life (age 40-49).",
      "page": 1,
      "mention_count": 2,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "scispacy_ner",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Cerebral Ventricle Neoplasms",
        "Brain Stem Neoplasms"
      ],
      "pubtator_normalized_name": "Brain Neoplasms",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "HIV/ AIDS",
      "preferred_label": "Acquired Immunodeficiency Syndrome",
      "abbreviation": null,
      "confidence": 0.8542663812637329,
      "is_rare_disease": false,
      "category": "immunology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": null,
        "orpha": null,
        "umls": "C0001175",
        "mesh": "D000163"
      },
      "all_identifiers": [
        {
          "system": "UMLS",
          "code": "C0001175",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D000163",
          "display": "Acquired Immunodeficiency Syndrome"
        }
      ],
      "context": "each year, for a total of approximately 1,500 new cases per year in the United States. PCNSL is slightly more common in males. The most common risk factor for the development of a primary CNS lymphoma is an impaired immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosuppressed groups include organ transplant recipients and individuals with congenital immunodeficiency syndromes. In fact, primary CNS lymphoma is the most common brain tumor in immunosuppressed pa",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "scispacy_ner",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Simian Acquired Immunodeficiency Syndrome",
        "Feline Acquired Immunodeficiency Syndrome",
        "Murine Acquired Immunodeficiency Syndrome"
      ],
      "pubtator_normalized_name": "Acquired Immunodeficiency Syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "congenital immunodeficiency syndromes",
      "preferred_label": "Congenital Immunodeficiency Diseases",
      "abbreviation": null,
      "confidence": 1.0,
      "is_rare_disease": false,
      "category": "immunology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": null,
        "orpha": null,
        "umls": "C0272229",
        "mesh": "D000081207"
      },
      "all_identifiers": [
        {
          "system": "UMLS",
          "code": "C0272229",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D000081207",
          "display": "Primary Immunodeficiency Diseases"
        }
      ],
      "context": "CNS lymphoma is an impaired immune system (immunosuppression). This is notably the case of patients living with HIV/ AIDS, especially those who are not treated who have a high viral load and low CD4+ cell count. Other immunosuppressed groups include organ transplant recipients and individuals with congenital immunodeficiency syndromes. In fact, primary CNS lymphoma is the most common brain tumor in immunosuppressed patients. The other main risk factor for developing a PCNSL is age. Most immunocompetent patients are diagnosed around age 60, although cases of PCNSL have also been reported in children. AIDS-related PCNSL most often",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "scispacy_ner",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Primary Immunodeficiency Diseases",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "AIDS-related",
      "preferred_label": "AIDS-Related Malignant Neoplasm",
      "abbreviation": null,
      "confidence": 0.9620600700378418,
      "is_rare_disease": false,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": null,
        "orpha": null,
        "umls": "C0280734",
        "mesh": null
      },
      "all_identifiers": [
        {
          "system": "UMLS",
          "code": "C0280734",
          "display": null
        }
      ],
      "context": "al immunodeficiency syndromes. In fact, primary CNS lymphoma is the most common brain tumor in immunosuppressed patients. The other main risk factor for developing a PCNSL is age. Most immunocompetent patients are diagnosed around age 60, although cases of PCNSL have also been reported in children. AIDS-related PCNSL most often develop during the fifth decade of life (age 40-49).",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "scispacy_ner",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    }
  ]
}